CD44 monoclonal antibody for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies

摘要

Compositions including an antibody specific for CD44 are provided. These antibodies specifically bind to hematologic malignant cells. Methods to use the CD44 antibodies to target cells expressing CD44 for therapeutic and diagnostic purposes are also provided.